Key Information

Gentian Diagnostics ASA serves the global market with sensitive diagnostic tests. Current and pipeline products contribute to improved diagnostics and cost reductions. The current portfolio and pipeline of efficient and accurate reagents span areas of inflammations, severe infections, kidney failures and congestive heart failures and veterinary healthcare. 

First quarter 2021 report

 

On 14th December, 2016, Gentian Diagnostics ASA was admitted to the Oslo Stock Exchange under GENT.

Find more information about the Gentian Share on Oslo Børs.
Learn more about Gentian Diagnostics ASA here.

4th of May 2021: Annual General Meeting

The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 4th May 2020 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.

Please find the notice incl. appendices enclosed here:

Financial Calendar 2021 

11TH FEB - QUARTERLY REPORT- Q4

16TH APR - ANNUAL REPORT

16TH APR - QUARTERLY REPORT - Q1

4TH MAY - ANNUAL GENERAL MEETING

25TH AUG - HALF-YEARLY REPORT

  • 25th August 2021 - Half-Yearly Report
  • 25th August 2021 - Half-Yearly Presentation

21ST OCT - QUARTERLY REPORT - Q3

  • 21st October 2021 - Quarterly Report - Q3
  • 21st October 2021 - Quarterly Presentation - Q3

 

Financial Calendar 2020

14TH FEB - QUARTERLY REPORT- Q4

24TH APR - ANNUAL REPORT

24TH APR - QUARTERLY REPORT - Q1

14TH MAY - ANNUAL GENERAL MEETING

21ST AUG - HALF-YEARLY REPORT

29TH OCT - QUARTERLY REPORT - Q3


14th of May 2020: Annual General Meeting

The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 14 May 2020 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.

Please find the notice incl. appendices enclosed here:

Historicals

Look at our historical archive to find financial reports and data from 2016-2019.